Exact Mass: 230.1419

Exact Mass Matches: 230.1419

Found 54 metabolites which its exact mass value is equals to given mass value 230.1419, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Camoensine

Oprea1_574945

C14H18N2O (230.1419)

Ibudilast

2-methyl-1-[2-(propan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one

C14H18N2O (230.1419)

Ibudilast is an anti-inflammatory and neuroprotective oral agent which shows an excellent safety profile at 60 mg/day and provides significantly prolonged time-to-first relapse and attenuated brain volume shrinkage in patients with relapsing-remitting (RR) and/or secondary progressive (SP) multiple sclerosis (MS). Ibudilast is currently in development in the U.S. (codes: AV-411 or MN-166), but is approved for use as an antiinflammatory in Japan. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DC - Leukotriene receptor antagonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Propyphenazone

1,5-dimethyl-2-phenyl-4-(propan-2-yl)-2,3-dihydro-1H-pyrazol-3-one

C14H18N2O (230.1419)

N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BB - Pyrazolones C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

5,6-Dehydroalbine

C14H18N2O (230.1419)

11alpha-Allylcytisine

C14H18N2O (230.1419)

Propyphenazone

4-Isopropylantipyrine

C14H18N2O (230.1419)

1,2-Dimethyl-6-methoxy-1,2,3,4-tetrahydro-beta-carboline

C14H18N2O (230.1419)

Alkaloid PA-I

C14H18N2O (230.1419)

1-propyl-2,3,4,9-tetrahydro-1H-beta-carbolin-6-ol|1-Propyl-6-hydroxy-1,2,3,4-tetrahydro-2-carboline|1-Propyl-6-hydroxyl-1,2,3,4-tetrahydro-beta-carboline|schobericine|schobicine

C14H18N2O (230.1419)

4-allyl-1,2,5,6,11,11a-hexahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-10-one|Dehydro-albin|Dehydroalbin

C14H18N2O (230.1419)

Propyphenazon

Propyphenazone

C14H18N2O (230.1419)

N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BB - Pyrazolones C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; INTERNAL_ID 4071 D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

Tabernanthalog

C14H18N2O (230.1419)

Ketas

2-methyl-1-[2-(propan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one

C14H18N2O (230.1419)

R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DC - Leukotriene receptor antagonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

BRL 54443 is a potent 5-HT1E/1F receptor agonist (Ki values are 1.1 nM and 0.7 nM respectively); displays > 30-fold selectivity over other 5-HT and dopamine receptors[1].

(1s,9r,12r)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,5-dien-4-one

C14H18N2O (230.1419)

(1s,9s,10r)-10-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C14H18N2O (230.1419)

7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadeca-2,4-dien-6-one

C14H18N2O (230.1419)

12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,5-dien-4-one

C14H18N2O (230.1419)

(1r,9r,10r)-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadeca-2,4-dien-6-one

C14H18N2O (230.1419)

(1s,9s,12r)-12-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,5-dien-4-one

C14H18N2O (230.1419)

(1s,9s,10s)-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadeca-2,4-dien-6-one

C14H18N2O (230.1419)

10-(prop-2-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C14H18N2O (230.1419)